Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health info online

This article was originally published in The Tan Sheet

Executive Summary

Only 3% of health information Web sites' references to phenylpropanolamine's weight loss properties provide "more than minimal coverage" and "completely correct" information, while 17% discuss PPA's stroke risk to same degree, Gretchen Berland, MD, UCLA, et al., conclude in study on Web health content's accessibility, accuracy and ease of understanding in May 23/30 Journal of the American Medical Association. Researchers evaluated 14 search engines' ability to connect users to appropriate sites and 25 Web sites' content and reading grade level. Forty-seven percent of online references to St. John's wort met the "more than minimal coverage" and "completely correct" criteria regarding botanical's use for mild depression and potential drug interactions; mere 7% of references to ephedra and weight loss were rated as up to par. Overall, only 19% of information on dietary supplements' general safety and effectiveness met study's standard

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel